Prof. Jennifer L. Garst
Duke Raleigh Cancer Center, USA
Email: jennifer.garst@duke.edu
Qualifications
1990 M.D., Medical College of Georgia
1986 B.Sc., University of Georgia
Publications (selected)
-
Porter LS, Keefe FJ, Davis D, Rumble
M, Scipio C, Garst J: Attachment styles in patients with lung cancer and their
spouses: associations with patient and spouse adjustment. Support Care
Cancer: Jan 13, 2012.
-
Govindan R, Bogart J, Stinchcombe T,
Wang X, Hodgson L, Kratzke R, Garst J, Brotherton T, Vokes EE. Randomized phase
II study of pemetrexed, carboplatin, and thoracic radiation with or without
cetuximab in patients with locally advanced unresectable non-small-cell lung
cancer: Cancer and Leukemia Group B trial 30407. J Clin Oncol. Aug 10;
29(23):3120-5, 2011.
-
Bastian LA, Fish LJ, Peterson BL,
Biddle AK, Garst J, Lyna P, Molner S, Bepler G, Kelley M, Keefe FJ, McBride CM.
Proactive recruitment of cancer patients' social networks into a smoking
cessation trial. Contemp Clin Trials. Jul; 32(4):498-504, 2011.
-
Ready N, Jänne PA, Bogart J,
Dipetrillo T, Garst J, Graziano S, Gu L, Wang X, Green MR, Vokes EE; Cancer,
Leukemia Group B Chemoradiotherapy and gefitinib in stage III non-small cell
lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer
and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. J Thorac
Oncol. Sept; 5(9):1382-90, 2010.
-
Porter LS, Keefe FJ, Garst J, Baucom
DH, McBride CM, McKee DC, Sutton L, Carson K, Knowles V, Rumble M, Scipio
C. Caregiver-Assisted Coping Skills Training for Lung Cancer: Results of a
Randomized Clinical Trial. J Pain Symptom Manage. Sept 9, 2010.
-
Ross H, Blumenschein G, Aisner J,
Damjanov, N, Dowlati A, Garst J, Rigas J, Smylie M, Hassani H, Allen K, Leopold
L, Zaks T, Shepard F: A Randomized Phase II Multicenter Trial Comparing
Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Subjects
with advanced or Metastatic Non-Small Cell Lung Cancer. Clin Cancer Res:
16; 1938, Mar 2010.
-
Daniel M, Keefe F, Lyna P, Peterson B,
Garst J, Kelley M, Bepler G, Bastian L: Persistent Smoking after a Diagnosis
of Lung Cancer is Associate with Higher Reported Pain Levels, J Pain:
10(3): 323–328, 2009.
-
Jones L, Eves N, Peterson B, Garst J,
Crawford J, West M, Mabe S, Harpole D, Kraus W, Douglas P: Safety and
feasibility of aerobic training on cardiopulmonary function and quality of life
in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer:
113(12):3430-9, 2008.
-
Porter LS, Keefe FJ, Garst J, McBride
C, Baucom D, Self-efficacy for Symptom Management in Patients With Lung
Cancer and Their Family Caregivers: Associations with Symptoms and
Distress. Pain, Jul15; 137(2):306-15, 2008.
-
Garst J. Topotecan: An Evolving
Option for the Treatment of Relapsed Small Cell Lung Cancer. Ther Clin Risk
Manag. Dec; 3(6):1087-95, 2007.
-
Mao J, Kocak Z, Zhou S, Garst J, Evans
E, Zhang J, Marks L. The Impact of Induction Chemotherapy and the
Associated Tumor Response on Subsequent Radiation-Related Changes in Lung
Function and Tumor Response. Int J Radiat Oncol Biol Phys, Feb 2007.
-
Schiffman SS, Sattely-Miller EA,
Taylor EL, Graham BG, Landerman LR, Zervakis J, Cohen HJ, Crawford J, Garst
JL. Combination of Flavor Enhancement and Chemosensory Education Improves
Nutritional Status in Older Cancer Patients. J Nutr Health Aging.
11(5):439-54, 2007.
-
Riedel RF, Andrews C, Garst J, Dunphy
F, Herndon JE, Blackwell S, Yowell S, Crawford J. A Phase II Trial of
Carboplatin/Vinorelbine with Pegfilgrastim Support for the Treatment of
Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol, Jun:
2(6):520-525, 2007.
-
Garst, J. Safety of Topotecan in
the Treatment of Recurrent Small-Cell Lung Cancer and Ovarian
Cancer. Expert Opinion on Drug Safety, 6(1):53-62, 2007.
-
Albright C and Garst J. Vaccine
Therapy in Non-small Cell Lung Cancer, Curr Onc Reports, 2007.
-
Riedel RF, Crawford J, Dunphy F,
Herndon JE, Padilla K, Garst J, Kelley MJ. Phase II Study of Carboplatin,
Irinotecan, and Thalidomide Combination in Patients with Extensive Stage
Small-Cell Lung Cancer. Lung Cancer, Dec; 54 (3): 431-432, 2006.
-
Anscher M, Garst J, Marks L, Larrier
N, Dunpy F, Vujaskovic Z, Zhou S, Dewhirst M, Shafman T, Crawford
J. Assessing the Ability of the Antiangiogenic and Anticytokine Agent
Thalidomide to Modulate Radiation-Induced Lung Injury, Int J Rad Oncol Biol
Phys: Aug 10, 2006.
-
Garst J, Herndon J, Shafman T,
Campagna L, Blackwell S, Padilla K, Bjurstrom T, Andrews C, Eaborn E, Anderson
E, Johnston E, Crawford J. A Phase I Study of Dose-Dense Topotecan Given
Upfront to Standard Chemotherapy for the Treatment of Small Cell Lung
Cancer. Clinical Drug Investigation 26 (5): 257-66, 2006.
-
Coscio AM, Garst, J. Lung Cancer
in Women. Current Oncology Reports 8:248-251, 2006.
-
Garst J, Whittington E. A Waste
of Taste: Taste Alterations During Cancer Therapy Can Make Food
Unenjoyable. Cure: 5(4), 2006.